Viatris (VTRS)
(Delayed Data from NSDQ)
$8.98 USD
+0.04 (0.45%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $8.98 0.00 (0.00%) 6:42 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2025
Time: BMO |
6/2025 | $0.56 | 0.00% |
Earnings Summary
For their last quarter, Viatris (VTRS) reported earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.49 per share. This reflects a positive earnings surprise of 2.04%. Look out for VTRS's next earnings release on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.56 per share, reflecting a year-over-year decrease of 18.84%.
Earnings History
Price & Consensus
Zacks News for VTRS
VTRS Down on Late-Stage Study Failure of Eye Disease Drug
VTRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises
VTRS FAQs
Viatris Inc. (VTRS) has announced they will report their next quarter earnings on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.56 per share, reflecting a year-over-year decrease of -18.84%.
Viatris Inc. has announced they will report their previous quarter earnings after the close of the market on August 07, 2025.
The Zacks Consensus Estimate for Viatris Inc. (VTRS) for the quarter ending June 2025 is $0.56 a share. We expect Viatris Inc. (VTRS) to report earnings in line with the consensus estimate of $0.56 per share
In the earnings report for the quarter ending in June 2024, Viatris Inc. (VTRS) announced earnings of $0.69 per share versus the Zacks Consensus Estimate of $0.68 per share, representing a surprise of 1.47%.